期刊
CANCER LETTERS
卷 357, 期 1, 页码 404-411出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.11.047
关键词
ICAT; Glioma; Wnt; beta-catenin; Proliferation
类别
资金
- National High Technology Research and Development Program 863 [2014AA021102, 2012AA02A508]
- China National Natural Scientific Fund [81372703, 81001128, 81101916]
- Natural Science Foundation of Tianjin Municipal Science and Technology Commission [12ZCDZSY17300]
Inhibitor of beta-catenin and T-cell factor (ICAT) is a key component of Wnt/beta-catenin signaling. ICAT blocks the formation of the beta-catenin/TCF complex and has been demonstrated to be involved in embryonic development and carcinogenesis. As an inhibitor of canonical Wnt signaling, ICAT was presumed to be a tumor-suppressor gene. However, the ICAT functions in human glioma remain unknown. In this study, we evaluated the expression of ICAT in 305 human glioma tissues and found that negative ICAT expression correlated with higher grade glioma and poor survival in patients with glioma. Then we transfected glioma cells with ICAT plasmid. Western blotting showed an increased ICAT protein expression level in glioma cells. MTT assay, flow cytometry and cell invasion assay were used to detect cell proliferation, cell cycle distribution, apoptosis and invasion. Our studies confirmed that ICAT inhibits glioma cell proliferation and invasion, and it induces cell apoptosis and cell cycle progression arrest. Besides, ICAT slowed down tumor growth in a glioblastoma xenograft model. Therefore, our study demonstrates that ICAT may serve as a tumor-suppressor in human glioma suggesting a promising direction for targeting therapy in glioma. (c) 2014 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据